02.08.12 State lawyers have recovered $25.2 million from five pharmaceutical companies sued over alleged inflation of Medicaid program drug costs, Louisiana Attorney General Buddy Caldwell's office said Tuesday.

The settlements are part of major litigation involving more than 100 companies accused of improperly reporting drug price information in order to increase reimbursements paid through the state's health insurance program for the poor.

Actavis, Boehringer Ingelheim, Dey, GlaxoSmithKline and Schering-Plough have agreed to settlements totaling $25.2 million.